82_FR_41796 82 FR 41627 - National Vaccine Injury Compensation Program; List of Petitions Received

82 FR 41627 - National Vaccine Injury Compensation Program; List of Petitions Received

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration

Federal Register Volume 82, Issue 169 (September 1, 2017)

Page Range41627-41629
FR Document2017-18567

HRSA is publishing this notice of petitions received under the National Vaccine Injury Compensation Program (the program), as required by the Public Health Service (PHS) Act, as amended. While the Secretary of HHS is named as the respondent in all proceedings brought by the filing of petitions for compensation under the Program, the United States Court of Federal Claims is charged by statute with responsibility for considering and acting upon the petitions.

Federal Register, Volume 82 Issue 169 (Friday, September 1, 2017) 
[Federal Register Volume 82, Number 169 (Friday, September 1, 2017)]
[Notices]
[Pages 41627-41629]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-18567]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


National Vaccine Injury Compensation Program; List of Petitions 
Received

AGENCY: Health Resources and Services Administration (HRSA), Department 
of Health and Human Services (HHS).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: HRSA is publishing this notice of petitions received under the 
National Vaccine Injury Compensation Program (the program), as required 
by the Public Health Service (PHS) Act, as amended. While the Secretary 
of HHS is named as the respondent in all proceedings brought by the 
filing of petitions for compensation under the Program, the United 
States Court of Federal Claims is charged by statute with 
responsibility for considering and acting upon the petitions.

FOR FURTHER INFORMATION CONTACT: For information about requirements for 
filing petitions, and the program in general, contact Lisa L. Reyes, 
Acting Clerk, United States Court of Federal Claims, 717 Madison Place 
NW., Washington, DC 20005, (202) 357-6400. For information on HRSA's 
role in the program, contact the Director, National Vaccine Injury 
Compensation Program, 5600 Fishers Lane, Room 08N146B, Rockville, MD 
20857; (301) 443-6593, or visit our Web site at: http://www.hrsa.gov/vaccinecompensation/index.html.

SUPPLEMENTARY INFORMATION: The program provides a system of no-fault 
compensation for certain individuals who have been injured by specified 
childhood vaccines. Subtitle 2 of Title XXI of the PHS Act, 42 U.S.C. 
300aa-10 et seq., provides that those seeking compensation are to file 
a petition with the U.S. Court of Federal Claims and to serve a copy of 
the petition on the Secretary of HHS, who is named as the respondent in 
each proceeding. The Secretary has delegated this responsibility under 
the program to HRSA. The Court is directed by statute to appoint 
special masters who take evidence, conduct hearings as appropriate, and 
make initial decisions as to eligibility for, and amount of, 
compensation.
    A petition may be filed with respect to injuries, disabilities, 
illnesses, conditions, and deaths resulting from vaccines described in 
the Vaccine Injury Table (the table) set forth at 42 CFR 100.3. This 
Table lists for each covered childhood vaccine the conditions that may 
lead to compensation and, for each condition, the time period for 
occurrence of the first symptom or manifestation of onset or of 
significant aggravation after vaccine administration. Compensation may 
also be awarded for conditions not listed in the Table and for 
conditions that are manifested outside the time periods specified in 
the Table, but only if the petitioner shows that the condition was 
caused by one of the listed vaccines.
    Section 2112(b)(2) of the PHS Act, 42 U.S.C. 300aa-12(b)(2), 
requires that ``[w]ithin 30 days after the Secretary receives service 
of any petition filed

[[Page 41628]]

under section 2111 the Secretary shall publish notice of such petition 
in the Federal Register.'' Set forth below is a list of petitions 
received by HRSA on July 1, 2017, through July 31, 2017. This list 
provides the name of petitioner, city and state of vaccination (if 
unknown then city and state of person or attorney filing claim), and 
case number. In cases where the Court has redacted the name of a 
petitioner and/or the case number, the list reflects such redaction.
    Section 2112(b)(2) also provides that the special master ``shall 
afford all interested persons an opportunity to submit relevant, 
written information'' relating to the following:
    1. The existence of evidence ``that there is not a preponderance of 
the evidence that the illness, disability, injury, condition, or death 
described in the petition is due to factors unrelated to the 
administration of the vaccine described in the petition,'' and
    2. Any allegation in a petition that the petitioner either:
    a. ``[S]ustained, or had significantly aggravated, any illness, 
disability, injury, or condition not set forth in the Vaccine Injury 
Table but which was caused by'' one of the vaccines referred to in the 
Table, or
    b. ``[S]ustained, or had significantly aggravated, any illness, 
disability, injury, or condition set forth in the Vaccine Injury Table 
the first symptom or manifestation of the onset or significant 
aggravation of which did not occur within the time period set forth in 
the Table but which was caused by a vaccine'' referred to in the Table.
    In accordance with Section 2112(b)(2), all interested persons may 
submit written information relevant to the issues described above in 
the case of the petitions listed below. Any person choosing to do so 
should file an original and three (3) copies of the information with 
the Clerk of the U.S. Court of Federal Claims at the address listed 
above (under the heading FOR FURTHER INFORMATION CONTACT), with a copy 
to HRSA addressed to Director, Division of Injury Compensation 
Programs, Healthcare Systems Bureau, 5600 Fishers Lane, 08N146B, 
Rockville, MD 20857. The Court's caption (Petitioner's Name v. 
Secretary of HHS) and the docket number assigned to the petition should 
be used as the caption for the written submission. Chapter 35 of title 
44, United States Code, related to paperwork reduction, does not apply 
to information required for purposes of carrying out the program.

    Dated: August 28, 2017.
George Sigounas,
Administrator.

List of Petitions Filed

1. Houston Byrd, Jr., Heath, Ohio, Court of Federal Claims No: 17-
0900V
2. Jacquelyn M. Will, Milwaukee, Wisconsin, Court of Federal Claims 
No: 17-0904V
3. Christine Midnight, Albuquerque, New Mexico, Court of Federal 
Claims No: 17-0905V
4. Beth Nemechek, Greeley, Colorado, Court of Federal Claims No: 17-
0907V
5. Patricia Woolf, Cheyenne, Wyoming, Court of Federal Claims No: 
17-0908V
6. Marie Schmidt, Naperville, Illinois, Court of Federal Claims No: 
17-0913V
7. Richard K. Parker, Richmond, Virginia, Court of Federal Claims 
No: 17-0917V
8. Ronald Skrajner, Aurora, Ohio, Court of Federal Claims No: 17-
0918V
9. Anita Javorski, Mankato, Minnesota, Court of Federal Claims No: 
17-0919V
10. Jose Solis Marin, Washington, District of Columbia, Court of 
Federal Claims No: 17-0920V
11. Lavell Maize, Boston, Massachusetts, Court of Federal Claims No: 
17-0921V
12. Ronald Patrick, Stuart, Florida, Court of Federal Claims No: 17-
0922V
13. Amy Mehl, Memphis, Tennessee, Court of Federal Claims No: 17-
0923V
14. Jennifer Stracick on behalf of H.S., St. Petersburg, Florida, 
Court of Federal Claims No: 17-0924V
15. Rebecca Curl, Winder, Georgia, Court of Federal Claims No: 17-
0925V
16. Martin McGrail and Amy McGrail on behalf of S.M., Neptune, New 
Jersey, Court of Federal Claims No: 17-0926V
17. Elizabeth Evans, New York, New York, Court of Federal Claims No: 
17-0929V
18. Arthur M. Flowers, III, West Columbia, South Carolina, Court of 
Federal Claims No: 17-0930V
19. Donna Ducey, Colleyville, Texas, Court of Federal Claims No: 17-
0933V
20. Mary Orloski, Lewiston, Maine, Court of Federal Claims No: 17-
0936V
21. Yvonne Simpson, Washington, District of Columbia, Court of 
Federal Claims No: 17-0944V
22. Leslie Questel on behalf of J.M., Big Bear, California, Court of 
Federal Claims No: 17-0946V
23. Erwin Casazza, Springfield, New Jersey, Court of Federal Claims 
No: 17-0947V
24. Tracie Johanek, Washington, District of Columbia, Court of 
Federal Claims No: 17-0948V
25. Kimberly Holway, Seattle, Washington, Court of Federal Claims 
No: 17-0949V
26. Livania Zavala, M.D. and Nelson J. Spinetti, M.D. on behalf of 
A.S., Edinburg, Texas, Court of Federal Claims No: 17-0951V
27. Fred A. Stover, Spring Mills, Pennsylvania, Court of Federal 
Claims No: 17-0952V
28. Justin M. Gillespie, Waupun, Wisconsin, Court of Federal Claims 
No: 17-0953V
29. Kevin McGuinness, Dade City, Florida, Court of Federal Claims 
No: 17-0954V
30. Kathleen Peddycord Wilson, Raleigh, North Carolina, Court of 
Federal Claims No: 17-0955V
31. Jamie Gardner, Camp Hill, Pennsylvania, Court of Federal Claims 
No: 17-0959V
32. Sharifah Wilson, Philadelphia, Pennsylvania, Court of Federal 
Claims No: 17-0960V
33. William Brown, Vienna, Virginia, Court of Federal Claims No: 17-
0961V
34. Karen Adams, Washington, District of Columbia, Court of Federal 
Claims No: 17-0963V
35. Stephen E. Antisdel, Buchanan, Michigan, Court of Federal Claims 
No: 17-0964V
36. Jennifer Gregorino, Chattanooga, Tennessee, Court of Federal 
Claims No: 17-0965V
37. Rowena Adcox, Bowling Green, Kentucky, Court of Federal Claims 
No: 17-0966V
38. Lisa Workman, Washington, District of Columbia, Court of Federal 
Claims No: 17-0967V
39. Mary Jane De La Pena, Sacramento, California, Court of Federal 
Claims No: 17-0971V
40. Mary Duncan, Washington, District of Columbia, Court of Federal 
Claims No: 17-0972V
41. Cindy Gilliam, Washington, District of Columbia, Court of 
Federal Claims No: 17-0974V
42. Jeffrey Braden, St. Louis, Missouri, Court of Federal Claims No: 
17-0975V
43. Janice Condara, Sugar Land, Texas, Court of Federal Claims No: 
17-0977V
44. George Kennedy, Austin, Texas, Court of Federal Claims No: 17-
0978V
45. Daphne Lattimer, Groveport, Ohio, Court of Federal Claims No: 
17-0980V
46. Linda Harris, Washington, District of Columbia, Court of Federal 
Claims No: 17-0981V
47. Kent Kemmerer, Willoughby, Ohio, Court of Federal Claims No: 17-
0982V
48. Casey Humphreys on behalf of E.H., Jasper, Arkansas, Court of 
Federal Claims No: 17-0983V
49. Deborah Langer, Dallas, Texas, Court of Federal Claims No: 17-
0984V
50. Allison Menard, Baton Rouge, Louisiana, Court of Federal Claims 
No: 17-0985V
51. William Nischbach, Washington, District of Columbia, Court of 
Federal Claims No: 17-0986V
52. Tzipora Lefkowitz on behalf of M.L., New Square, New York, Court 
of Federal Claims No: 17-0987V
53. Sara Torres-Ruiz, Palmdale, California, Court of Federal Claims 
No: 17-0988V
54. Jason Quirino, Boston, Massachusetts, Court of Federal Claims 
No: 17-0989V
55. Barbara Stoliker, Ventura, California, Court of Federal Claims 
No: 17-0990V
56. Natalie Ben-Shoshan, Dallas, Texas, Court of Federal Claims No: 
17-0991V
57. Patricia Pendergrass, Washington, District of Columbia, Court of 
Federal Claims No: 17-0992V
58. Jamie Miller, Baltimore, Maryland, Court of Federal Claims No: 
17-0993V
59. Regina Stenberg, Washington, District of Columbia, Court of 
Federal Claims No: 17-0994V
60. Cheri Lang, Washington, District of Columbia, Court of Federal 
Claims No:

[[Page 41629]]

17-0995V
61. Cheryl Conkle, Boston, Massachusetts, Court of Federal Claims 
No: 17-1001V
62. Angela Dieter, Mount Joy, Pennsylvania, Court of Federal Claims 
No: 17-1002V
63. Romana Estes, Boston, Massachusetts, Court of Federal Claims No: 
17-1003V
64. Anne Knudson, Phillips, Wisconsin, Court of Federal Claims No: 
17-1004V
65. Miguel Leal, Jr., Wyoming, Michigan, Court of Federal Claims No: 
17-1008V
66. Kimberly Settle, Thomasville, North Carolina, Court of Federal 
Claims No: 17-1009V
67. Sapna Kadakia, Washington, District of Columbia, Court of 
Federal Claims No: 17-1011V
68. Ricky Buras, Hattiesburg, Mississippi, Court of Federal Claims 
No: 17-1012V
69. Ellisa Morine, Chicago, Illinois, Court of Federal Claims No: 
17-1013V
70. Margaret Rogers, Dresher, Pennsylvania, Court of Federal Claims 
No: 17-1014V
71. Michael Anderson, Dresher, Pennsylvania, Court of Federal Claims 
No: 17-1017V
72. Robert Wechsler, Dresher, Pennsylvania, Court of Federal Claims 
No: 17-1018V
73. Geraldine Petrocelli, Monroe, New York, Court of Federal Claims 
No: 17-1019V
74. Kevin McKenna, Rochester Hills, Michigan, Court of Federal 
Claims No: 17-1021V
75. Albert Parsons, Wartburg, Tennessee, Court of Federal Claims No: 
17-1022V
76. Cynthia Hackney, San Antonio, Texas, Court of Federal Claims No: 
17-1027V
77. Barbara Sakovits, Dresher, Pennsylvania, Court of Federal Claims 
No: 17-1028V
78. Sheryl Attig, Greenville, South Carolina, Court of Federal 
Claims No: 17-1029V
79. Patricia Anton, Dresher, Pennsylvania, Court of Federal Claims 
No: 17-1031V
80. Tasha Lee and Jose Botello on behalf of A.B., Beverly Hills, 
California, Court of Federal Claims No: 17-1032V

[FR Doc. 2017-18567 Filed 8-31-17; 8:45 am]
BILLING CODE 4165-15-P

Federal Register / Vol. 82, No. 169 / Friday, September 1, 2017 / Notices 41627 product for which FDA has regulatory Reduction Act of 1995 (44 U.S.C. 3501– Program (the program), as required by responsibility. 3520). The collections of information in the Public Health Service (PHS) Act, as In the Federal Register of April 1, 21 CFR part 807, subpart E have been amended. While the Secretary of HHS is 2015 (80 FR 17439), FDA announced the approved under OMB control number named as the respondent in all availability of the draft guidance. 0910–0120; the collections of proceedings brought by the filing of Interested persons were invited to information in 21 CFR part 860 have petitions for compensation under the comment by June 1, 2015. FDA revised been approved under OMB control Program, the United States Court of the guidance as appropriate in response number 0910–0138; the collections of Federal Claims is charged by statute to the comments. This guidance is information in 21 CFR part 814 have with responsibility for considering and intended to provide information for been approved under OMB control acting upon the petitions. industry and for CDRH staff on the number 0910–0231; and the collections FOR FURTHER INFORMATION CONTACT: For processes associated with a panel of information in 21 CFR part 814, information about requirements for meeting held for any of the reasons subpart H have been approved under filing petitions, and the program in identified in the guidance. This OMB control number 0910–0332. general, contact Lisa L. Reyes, Acting guidance replaces the ‘‘Guidance on Clerk, United States Court of Federal Amended Procedures for Advisory V. References Claims, 717 Madison Place NW., Panel Meetings’’ (Ref. 2) and the The following references are on Washington, DC 20005, (202) 357–6400. guidance document entitled ‘‘Panel display in the Dockets Management For information on HRSA’s role in the Review of Premarket Approval Staff (see ADDRESSES), and may be seen program, contact the Director, National Applications #P91–2 blue book memo’’ by interested persons between 9 a.m. Vaccine Injury Compensation Program, (Ref. 3). This guidance supplements and 4 p.m., Monday through Friday; 5600 Fishers Lane, Room 08N146B, existing FDA Agency-wide guidance on they are also available electronically at Rockville, MD 20857; (301) 443–6593, the conduct of Advisory Committee https://www.regulations.gov. FDA has or visit our Web site at: http:// meetings. verified the Web site addresses, as of the www.hrsa.gov/vaccinecompensation/ date this document publishes in the index.html. II. Significance of Guidance Federal Register, but Web sites are This guidance is being issued SUPPLEMENTARY INFORMATION: The subject to change over time. consistent with FDA’s good guidance program provides a system of no-fault 1. CDRH’s Medical Devices Advisory compensation for certain individuals practices regulation (21 CFR 10.115). Committee, available at https:// The guidance represents the current who have been injured by specified www.fda.gov/AdvisoryCommittees/ thinking of FDA on the panel meeting CommitteesMeetingMaterials/Medical childhood vaccines. Subtitle 2 of Title process for medical devices. It does not Devices/MedicalDevicesAdvisoryCommittee/ XXI of the PHS Act, 42 U.S.C. 300aa– establish any rights for any person and default.htm. 10 et seq., provides that those seeking is not binding on FDA or the public. 2. ‘‘Guidance for Industry and FDA Staff: compensation are to file a petition with You can use an alternative approach if Guidance on Amended Procedures for the U.S. Court of Federal Claims and to Advisory Panel Meetings,’’ July 2000, serve a copy of the petition on the it satisfies the requirements of the available at https://www.fda.gov/downloads/ applicable statutes and regulations. This Secretary of HHS, who is named as the MedicalDevices/DeviceRegulationand guidance is not subject to Executive Guidance/GuidanceDocuments/ respondent in each proceeding. The Order 12866. ucm073726.pdf. Secretary has delegated this 3. ‘‘Panel Review of Premarket Approval responsibility under the program to III. Electronic Access Applications #P91–2 (blue book memo),’’ HRSA. The Court is directed by statute Persons interested in obtaining a copy May 1991, available at https://www.fda.gov/ to appoint special masters who take of the guidance may do so by MedicalDevices/DeviceRegulationand evidence, conduct hearings as downloading an electronic copy from Guidance/GuidanceDocuments/ appropriate, and make initial decisions ucm081363.htm. as to eligibility for, and amount of, the internet. A search capability for all Center for Devices and Radiological Dated: August 28, 2017. compensation. Health guidance documents is available Anna K. Abram, A petition may be filed with respect at https://www.fda.gov/MedicalDevices/ Deputy Commissioner for Policy, Planning, to injuries, disabilities, illnesses, DeviceRegulationandGuidance/ Legislation, and Analysis. conditions, and deaths resulting from GuidanceDocuments/default.htm. [FR Doc. 2017–18549 Filed 8–31–17; 8:45 am] vaccines described in the Vaccine Injury Guidance documents are also available BILLING CODE 4164–01–P Table (the table) set forth at 42 CFR at https://www.regulations.gov. Persons 100.3. This Table lists for each covered unable to download an electronic copy childhood vaccine the conditions that of ‘‘Procedures for Meetings of the DEPARTMENT OF HEALTH AND may lead to compensation and, for each Medical Devices Advisory Committee’’ HUMAN SERVICES condition, the time period for may send an email request to CDRH- occurrence of the first symptom or Guidance@fda.hhs.gov to receive an Health Resources and Services manifestation of onset or of significant electronic copy of the document. Please Administration aggravation after vaccine use the document number 413 to administration. Compensation may also National Vaccine Injury Compensation be awarded for conditions not listed in identify the guidance you are Program; List of Petitions Received the Table and for conditions that are requesting. sradovich on DSK3GMQ082PROD with NOTICES AGENCY: Health Resources and Services manifested outside the time periods IV. Paperwork Reduction Act of 1995 specified in the Table, but only if the Administration (HRSA), Department of This guidance refers to previously Health and Human Services (HHS). petitioner shows that the condition was approved collections of information ACTION: Notice. caused by one of the listed vaccines. found in FDA regulations. These Section 2112(b)(2) of the PHS Act, 42 collections of information are subject to SUMMARY: HRSA is publishing this U.S.C. 300aa–12(b)(2), requires that review by the Office of Management and notice of petitions received under the ‘‘[w]ithin 30 days after the Secretary Budget (OMB) under the Paperwork National Vaccine Injury Compensation receives service of any petition filed VerDate Sep<11>2014 17:53 Aug 31, 2017 Jkt 241001 PO 00000 Frm 00041 Fmt 4703 Sfmt 4703 E:\FR\FM\01SEN1.SGM 01SEN1

41628 Federal Register / Vol. 82, No. 169 / Friday, September 1, 2017 / Notices under section 2111 the Secretary shall Dated: August 28, 2017. No: 17–0955V publish notice of such petition in the George Sigounas, 31. Jamie Gardner, Camp Hill, Pennsylvania, Court of Federal Claims No: 17–0959V Federal Register.’’ Set forth below is a Administrator. 32. Sharifah Wilson, Philadelphia, list of petitions received by HRSA on Pennsylvania, Court of Federal Claims List of Petitions Filed July 1, 2017, through July 31, 2017. This No: 17–0960V list provides the name of petitioner, city 1. Houston Byrd, Jr., Heath, Ohio, Court of 33. William Brown, Vienna, Virginia, Court and state of vaccination (if unknown Federal Claims No: 17–0900V of Federal Claims No: 17–0961V 2. Jacquelyn M. Will, Milwaukee, Wisconsin, 34. Karen Adams, Washington, District of then city and state of person or attorney Court of Federal Claims No: 17–0904V filing claim), and case number. In cases Columbia, Court of Federal Claims No: 3. Christine Midnight, Albuquerque, New 17–0963V where the Court has redacted the name Mexico, Court of Federal Claims No: 17– 35. Stephen E. Antisdel, Buchanan, of a petitioner and/or the case number, 0905V Michigan, Court of Federal Claims No: the list reflects such redaction. 4. Beth Nemechek, Greeley, Colorado, Court 17–0964V of Federal Claims No: 17–0907V 36. Jennifer Gregorino, Chattanooga, Section 2112(b)(2) also provides that 5. Patricia Woolf, Cheyenne, Wyoming, Court Tennessee, Court of Federal Claims No: the special master ‘‘shall afford all of Federal Claims No: 17–0908V 17–0965V interested persons an opportunity to 6. Marie Schmidt, Naperville, Illinois, Court 37. Rowena Adcox, Bowling Green, submit relevant, written information’’ of Federal Claims No: 17–0913V Kentucky, Court of Federal Claims No: relating to the following: 7. Richard K. Parker, Richmond, Virginia, 17–0966V Court of Federal Claims No: 17–0917V 38. Lisa Workman, Washington, District of 1. The existence of evidence ‘‘that 8. Ronald Skrajner, Aurora, Ohio, Court of Columbia, Court of Federal Claims No: there is not a preponderance of the Federal Claims No: 17–0918V 17–0967V evidence that the illness, disability, 9. Anita Javorski, Mankato, Minnesota, Court 39. Mary Jane De La Pena, Sacramento, injury, condition, or death described in of Federal Claims No: 17–0919V California, Court of Federal Claims No: the petition is due to factors unrelated 10. Jose Solis Marin, Washington, District of 17–0971V Columbia, Court of Federal Claims No: 40. Mary Duncan, Washington, District of to the administration of the vaccine 17–0920V described in the petition,’’ and Columbia, Court of Federal Claims No: 11. Lavell Maize, Boston, Massachusetts, 17–0972V 2. Any allegation in a petition that the Court of Federal Claims No: 17–0921V 41. Cindy Gilliam, Washington, District of petitioner either: 12. Ronald Patrick, Stuart, Florida, Court of Columbia, Court of Federal Claims No: Federal Claims No: 17–0922V a. ‘‘[S]ustained, or had significantly 17–0974V 13. Amy Mehl, Memphis, Tennessee, Court aggravated, any illness, disability, 42. Jeffrey Braden, St. Louis, Missouri, Court of Federal Claims No: 17–0923V of Federal Claims No: 17–0975V injury, or condition not set forth in the 14. Jennifer Stracick on behalf of H.S., St. 43. Janice Condara, Sugar Land, Texas, Court Vaccine Injury Table but which was Petersburg, Florida, Court of Federal of Federal Claims No: 17–0977V caused by’’ one of the vaccines referred Claims No: 17–0924V 44. George Kennedy, Austin, Texas, Court of 15. Rebecca Curl, Winder, Georgia, Court of to in the Table, or Federal Claims No: 17–0925V Federal Claims No: 17–0978V b. ‘‘[S]ustained, or had significantly 16. Martin McGrail and Amy McGrail on 45. Daphne Lattimer, Groveport, Ohio, Court behalf of S.M., Neptune, New Jersey, of Federal Claims No: 17–0980V aggravated, any illness, disability, 46. Linda Harris, Washington, District of injury, or condition set forth in the Court of Federal Claims No: 17–0926V 17. Elizabeth Evans, New York, New York, Columbia, Court of Federal Claims No: Vaccine Injury Table the first symptom 17–0981V Court of Federal Claims No: 17–0929V or manifestation of the onset or 18. Arthur M. Flowers, III, West Columbia, 47. Kent Kemmerer, Willoughby, Ohio, Court significant aggravation of which did not South Carolina, Court of Federal Claims of Federal Claims No: 17–0982V occur within the time period set forth in No: 17–0930V 48. Casey Humphreys on behalf of E.H., the Table but which was caused by a 19. Donna Ducey, Colleyville, Texas, Court of Jasper, Arkansas, Court of Federal Claims Federal Claims No: 17–0933V No: 17–0983V vaccine’’ referred to in the Table. 20. Mary Orloski, Lewiston, Maine, Court of 49. Deborah Langer, Dallas, Texas, Court of In accordance with Section Federal Claims No: 17–0936V Federal Claims No: 17–0984V 2112(b)(2), all interested persons may 21. Yvonne Simpson, Washington, District of 50. Allison Menard, Baton Rouge, Louisiana, submit written information relevant to Columbia, Court of Federal Claims No: Court of Federal Claims No: 17–0985V the issues described above in the case of 17–0944V 51. William Nischbach, Washington, District 22. Leslie Questel on behalf of J.M., Big Bear, of Columbia, Court of Federal Claims No: the petitions listed below. Any person California, Court of Federal Claims No: 17–0986V choosing to do so should file an original 52. Tzipora Lefkowitz on behalf of M.L., New 17–0946V and three (3) copies of the information 23. Erwin Casazza, Springfield, New Jersey, Square, New York, Court of Federal with the Clerk of the U.S. Court of Court of Federal Claims No: 17–0947V Claims No: 17–0987V Federal Claims at the address listed 24. Tracie Johanek, Washington, District of 53. Sara Torres-Ruiz, Palmdale, California, above (under the heading FOR FURTHER Columbia, Court of Federal Claims No: Court of Federal Claims No: 17–0988V INFORMATION CONTACT), with a copy to 17–0948V 54. Jason Quirino, Boston, Massachusetts, HRSA addressed to Director, Division of 25. Kimberly Holway, Seattle, Washington, Court of Federal Claims No: 17–0989V Court of Federal Claims No: 17–0949V 55. Barbara Stoliker, Ventura, California, Injury Compensation Programs, Court of Federal Claims No: 17–0990V 26. Livania Zavala, M.D. and Nelson J. Healthcare Systems Bureau, 5600 Spinetti, M.D. on behalf of A.S., 56. Natalie Ben-Shoshan, Dallas, Texas, Court Fishers Lane, 08N146B, Rockville, MD Edinburg, Texas, Court of Federal Claims of Federal Claims No: 17–0991V 20857. The Court’s caption (Petitioner’s No: 17–0951V 57. Patricia Pendergrass, Washington, District Name v. Secretary of HHS) and the 27. Fred A. Stover, Spring Mills, of Columbia, Court of Federal Claims No: sradovich on DSK3GMQ082PROD with NOTICES docket number assigned to the petition Pennsylvania, Court of Federal Claims 17–0992V should be used as the caption for the No: 17–0952V 58. Jamie Miller, Baltimore, Maryland, Court 28. Justin M. Gillespie, Waupun, Wisconsin, of Federal Claims No: 17–0993V written submission. Chapter 35 of title 59. Regina Stenberg, Washington, District of Court of Federal Claims No: 17–0953V 44, United States Code, related to 29. Kevin McGuinness, Dade City, Florida, Columbia, Court of Federal Claims No: paperwork reduction, does not apply to Court of Federal Claims No: 17–0954V 17–0994V information required for purposes of 30. Kathleen Peddycord Wilson, Raleigh, 60. Cheri Lang, Washington, District of carrying out the program. North Carolina, Court of Federal Claims Columbia, Court of Federal Claims No: VerDate Sep<11>2014 17:53 Aug 31, 2017 Jkt 241001 PO 00000 Frm 00042 Fmt 4703 Sfmt 4703 E:\FR\FM\01SEN1.SGM 01SEN1

Federal Register / Vol. 82, No. 169 / Friday, September 1, 2017 / Notices 41629 17–0995V would constitute a clearly unwarranted Contact Person: Jian Yang, Ph.D., Scientific 61. Cheryl Conkle, Boston, Massachusetts, invasion of personal privacy. Review Officer, Review Branch, DEA, Court of Federal Claims No: 17–1001V NIDDK, National Institutes of Health, Room 62. Angela Dieter, Mount Joy, Pennsylvania, Name of Committee: Center for Scientific 7111, 6707 Democracy Boulevard, Bethesda, Court of Federal Claims No: 17–1002V Review Special Emphasis Panel; PAR 14– MD 20892–5452, (301) 594–7799, yangj@ 63. Romana Estes, Boston, Massachusetts, 166: Early Phase Clinical Trials in Imaging extra.niddk.nih.gov. Court of Federal Claims No: 17–1003V and Image-Guided Interventions. Name of Committee: National Institute of 64. Anne Knudson, Phillips, Wisconsin, Date: September 25, 2017. Diabetes and Digestive and Kidney Diseases Court of Federal Claims No: 17–1004V Time: 4:00 p.m. to 7:00 p.m. Special Emphasis Panel; Time-Sensitive 65. Miguel Leal, Jr., Wyoming, Michigan, Agenda: To review and evaluate grant Obesity PAR Review. Court of Federal Claims No: 17–1008V applications. Date: September 29, 2017. 66. Kimberly Settle, Thomasville, North Place: Bethesda North Marriott Hotel & Time: 1:30 p.m. to 3:30 p.m. Carolina, Court of Federal Claims No: Conference Center, 5701 Marinelli Road, Agenda: To review and evaluate grant 17–1009V Bethesda, MD 20852. applications. 67. Sapna Kadakia, Washington, District of Contact Person: Songtao Liu, MD, Place: National Institutes of Health, Two Columbia, Court of Federal Claims No: Scientific Review Officer, Center for Democracy Plaza, 6707 Democracy 17–1011V Scientific Review, National Institutes of Boulevard, Bethesda, MD 20892 (Telephone 68. Ricky Buras, Hattiesburg, Mississippi, Health, 6701 Rockledge Drive, Room 5108, Conference Call). Court of Federal Claims No: 17–1012V Bethesda, MD 20817, 301–435–3578, Contact Person: Michele L. Barnard, Ph.D., 69. Ellisa Morine, Chicago, Illinois, Court of songtao.liu@nih.gov. Scientific Review Officer, Review Branch, Federal Claims No: 17–1013V (Catalogue of Federal Domestic Assistance DEA, NIDDK, National Institutes of Health, 70. Margaret Rogers, Dresher, Pennsylvania, Program Nos. 93.306, Comparative Medicine; Room 7353, 6707 Democracy Boulevard, Court of Federal Claims No: 17–1014V 93.333, Clinical Research, 93.306, 93.333, Bethesda, MD 20892–2542, (301) 594–8898, 71. Michael Anderson, Dresher, 93.337, 93.393–93.396, 93.837–93.844, barnardm@extra.niddk.nih.gov. Pennsylvania, Court of Federal Claims 93.846–93.878, 93.892, 93.893, National Name of Committee: National Institute of No: 17–1017V Institutes of Health, HHS) Diabetes and Digestive and Kidney Diseases 72. Robert Wechsler, Dresher, Pennsylvania, Dated: August 29, 2017. Special Emphasis Panel; DDK–D Member Court of Federal Claims No: 17–1018V Conflict SEP. Natasha M. Copeland, 73. Geraldine Petrocelli, Monroe, New York, Date: October 6, 2017. Court of Federal Claims No: 17–1019V Program Analyst, Office of Federal Advisory Time: 8:00 a.m. to 4:00 p.m. 74. Kevin McKenna, Rochester Hills, Committee Policy. Agenda: To review and evaluate grant Michigan, Court of Federal Claims No: [FR Doc. 2017–18612 Filed 8–31–17; 8:45 am] applications. 17–1021V BILLING CODE 4140–01–P Place: Residence Inn Bethesda, 7335 75. Albert Parsons, Wartburg, Tennessee, Wisconsin Avenue, Bethesda, MD 20814. Court of Federal Claims No: 17–1022V Contact Person: Xiaodu Guo, MD, Ph.D., 76. Cynthia Hackney, San Antonio, Texas, DEPARTMENT OF HEALTH AND Scientific Review Officer, Review Branch, Court of Federal Claims No: 17–1027V DEA, NIDDK, National Institutes of Health, HUMAN SERVICES 77. Barbara Sakovits, Dresher, Pennsylvania, Room 7023, 6707 Democracy Boulevard, Court of Federal Claims No: 17–1028V Bethesda, MD 20892–5452, (301) 594–4719, National Institutes of Health 78. Sheryl Attig, Greenville, South Carolina, guox@extra.niddk.nih.gov. Court of Federal Claims No: 17–1029V National Institute of Diabetes and Name of Committee: National Institute of 79. Patricia Anton, Dresher, Pennsylvania, Court of Federal Claims No: 17–1031V Digestive and Kidney Diseases; Notice Diabetes and Digestive and Kidney Diseases of Closed Meetings Special Emphasis Panel; Fellowships in 80. Tasha Lee and Jose Botello on behalf of Digestive Diseases and Nutrition. A.B., Beverly Hills, California, Court of Federal Claims No: 17–1032V Pursuant to section 10(d) of the Date: October 12–13, 2017. Federal Advisory Committee Act, as Time: 8:00 a.m. to 5:00 p.m. [FR Doc. 2017–18567 Filed 8–31–17; 8:45 am] Agenda: To review and evaluate grant amended, notice is hereby given of the BILLING CODE 4165–15–P following meetings. applications. Place: Bethesda North Marriott Hotel & The meetings will be closed to the Conference Center, 5701 Marinelli Road, public in accordance with the Bethesda, MD 20852. DEPARTMENT OF HEALTH AND provisions set forth in sections Contact Person: Jian Yang, Ph.D., Scientific HUMAN SERVICES 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Review Officer, Review Branch, DEA, National Institutes of Health as amended. The grant applications and NIDDK, National Institutes of Health, Room the discussions could disclose 7111, 6707 Democracy Boulevard, Bethesda, Center For Scientific Review; Notice of confidential trade secrets or commercial MD 20892–5452, (301) 594–7799, yangj@ Closed Meeting property such as patentable material, extra.niddk.nih.gov. and personal information concerning Name of Committee: National Institute of Pursuant to section 10(d) of the individuals associated with the grant Diabetes and Digestive and Kidney Diseases Federal Advisory Committee Act, as applications, the disclosure of which Special Emphasis Panel; Fellowships in amended, notice is hereby given of the Diabetes, Endocrinology and Metabolic would constitute a clearly unwarranted Diseases. following meeting. invasion of personal privacy. Date: October 17, 2017. The meeting will be closed to the Name of Committee: National Institute of Time: 8:00 a.m. to 6:00 p.m. public in accordance with the Diabetes and Digestive and Kidney Diseases Agenda: To review and evaluate grant provisions set forth in sections Special Emphasis Panel; R13 Conference applications. 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Grant Applications. Place: Doubletree Hotel Bethesda sradovich on DSK3GMQ082PROD with NOTICES as amended. The grant applications and Date: September 21, 2017. (Formerly Holiday Inn Select), 8120 Time: 11:00 a.m. to 12:30 p.m. Wisconsin Avenue, Bethesda, MD 20814. the discussions could disclose Agenda: To review and evaluate grant Contact Person: Thomas A. Tatham, Ph.D., confidential trade secrets or commercial applications. Scientific Review Officer, Review Branch, property such as patentable material, Place: National Institutes of Health, Two DEA, NIDDK, National Institutes of Health, and personal information concerning Democracy Plaza, 6707 Democracy Room 7021, 6707 Democracy Boulevard, individuals associated with the grant Boulevard, Bethesda, MD 20892 (Telephone Bethesda, MD 20892–5452, (301) 594–3993, applications, the disclosure of which Conference Call). tathamt@mail.nih.gov. VerDate Sep<11>2014 17:53 Aug 31, 2017 Jkt 241001 PO 00000 Frm 00043 Fmt 4703 Sfmt 4703 E:\FR\FM\01SEN1.SGM 01SEN1


Document Created: 2017-09-01 01:50:52
Document Modified: 2017-09-01 01:50:52
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
ActionNotice.
ContactFor information about requirements for filing petitions, and the program in general, contact Lisa L. Reyes, Acting Clerk, United States Court of Federal Claims, 717 Madison Place NW., Washington, DC 20005, (202) 357-6400. For information on HRSA's role in the program, contact the Director, National Vaccine Injury Compensation Program, 5600 Fishers Lane, Room 08N146B, Rockville, MD 20857; (301) 443-6593, or visit our Web site at: http://www.hrsa.gov/ vaccinecompensation/index.html.
FR Citation82 FR 41627 
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR